Sfoglia per Autore
Mostrati risultati da 1 a 8 di 8
A pharmacokinetics approach to drug interactions.
2004 Camaggi CM; Strocchi E.
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers
2004 Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D’Angelo R; Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM
A comparative study on Capecitabine (Cape) pharmacokinetics (PK) in elderly or younger patients with metastatic breast (MBC) or colo-rectal cancer (CRC)
2006 C. Longobardi; E. Strocchi; F. Di Fabio; C. M. Camaggi; N. Zoli; A. A. Martoni
High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study
2007 Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Barate C; Camaggi CM; Morra E.
Novel Pyrazoles as Inhibitors of the Receptor of the TGF- Factor for Targeted Drug Delivery. In vitro Anti Cancer Activity Evaluation Against Malignant Gliomas.
2008 B. F. Bonini; C. M. Camaggi; Mauro Comes Franchini; D. Gentili; E. Magrini; A. Pession; M. Rani; A. Pucci; E. Strocchi
Sample Variability of Serum “Albuminome” MALDI Signature for Early Diagnosis of Hepatocellular Carcinoma (HCC): Comparison of Different Methods of Preparation.
2009 P.Bruschi; C.M. Camaggi; M. Cantù; D. Eletto; E. Strocchi; F.Genovese; L.Gramantieri; P.Chieco; L.Bolondi
NANOCARRIERS CONTAINING MULTIKINASES INHIBITORS FOR DRUG DELIVERY. NANOMEDICINE APPLICATIONS AGAINST MALIGNANT GLIOBLASTOMA
2009 M. Comes-Franchini; D. Gentili; A. Pession; C. M. Camaggi; E. Strocchi
Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas. Eur J Med Chem. 2010; 45: 2024-33
2010 M. Comes Franchini; B. F. Bonini; C.M. Camaggi; D. Gentili; A. Pession; M. Rani; E. Strocchi
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A pharmacokinetics approach to drug interactions. | Camaggi CM; Strocchi E. | 2004-01-01 | - | International Society of Oncology Pharmacy Practit | 4.01 Contributo in Atti di convegno | - |
| Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers | Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D’Angelo R;... Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM | 2004-01-01 | EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A comparative study on Capecitabine (Cape) pharmacokinetics (PK) in elderly or younger patients with metastatic breast (MBC) or colo-rectal cancer (CRC) | C. Longobardi; E. Strocchi; F. Di Fabio; C. M. Camaggi; N. Zoli; A. A. Martoni | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study | Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; ...Barate C; Camaggi CM; Morra E. | 2007-01-01 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Novel Pyrazoles as Inhibitors of the Receptor of the TGF- Factor for Targeted Drug Delivery. In vitro Anti Cancer Activity Evaluation Against Malignant Gliomas. | B. F. Bonini; C. M. Camaggi; Mauro Comes Franchini; D. Gentili; E. Magrini; A. Pession; M. Rani; ...A. Pucci; E. Strocchi | 2008-01-01 | - | Società Chimica Italiana | 4.02 Riassunto (Abstract) | - |
| Sample Variability of Serum “Albuminome” MALDI Signature for Early Diagnosis of Hepatocellular Carcinoma (HCC): Comparison of Different Methods of Preparation. | P.Bruschi; C.M. Camaggi; M. Cantù; D. Eletto; E. Strocchi; F.Genovese; L.Gramantieri; P.Chieco; L....Bolondi | 2009-01-01 | - | Italian Proteomics Association | 4.02 Riassunto (Abstract) | - |
| NANOCARRIERS CONTAINING MULTIKINASES INHIBITORS FOR DRUG DELIVERY. NANOMEDICINE APPLICATIONS AGAINST MALIGNANT GLIOBLASTOMA | M. Comes-Franchini; D. Gentili; A. Pession; C. M. Camaggi; E. Strocchi | 2009-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas. Eur J Med Chem. 2010; 45: 2024-33 | M. Comes Franchini; B. F. Bonini; C.M. Camaggi; D. Gentili; A. Pession; M. Rani; E. Strocchi | 2010-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Mostrati risultati da 1 a 8 di 8
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile